Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
Identifieur interne : 001396 ( Main/Corpus ); précédent : 001395; suivant : 001397Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
Auteurs : Sun In Hong ; Byung-Han Ryu ; Yong Pil Chong ; Seungjun Lee ; Sunjoo Kim ; Ho Cheol Kim ; Kyung-Wook Hong ; In-Gyu Bae ; Oh-Hyun ChoSource :
- International journal of antimicrobial agents [ 1872-7913 ] ; 2020.
English descriptors
- KwdEn :
- Adjuvants, Immunologic (administration & dosage), Adult (MeSH), Aged (MeSH), Antimalarials (administration & dosage), Antiviral Agents (administration & dosage), Betacoronavirus (growth & development), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (pathology), Drug Therapy, Combination (methods), Female (MeSH), Humans (MeSH), Hydroxychloroquine (administration & dosage), Interferon beta-1b (administration & dosage), Lopinavir (administration & dosage), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia (drug therapy), Pneumonia, Viral (drug therapy), Pneumonia, Viral (pathology), Ritonavir (administration & dosage), SARS-CoV-2 (MeSH), Treatment Outcome (MeSH).
- MESH :
- chemical , administration & dosage : Adjuvants, Immunologic, Antimalarials, Antiviral Agents, Hydroxychloroquine, Interferon beta-1b, Lopinavir, Ritonavir.
- drug therapy : Coronavirus Infections, Pneumonia, Pneumonia, Viral.
- growth & development : Betacoronavirus.
- methods : Drug Therapy, Combination.
- pathology : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, COVID-19, Female, Humans, Male, Middle Aged, Pandemics, SARS-CoV-2, Treatment Outcome.
DOI: 10.1016/j.ijantimicag.2020.106052
PubMed: 32544570
PubMed Central: PMC7293467
Links to Exploration step
pubmed:32544570Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.</title><author><name sortKey="Hong, Sun In" sort="Hong, Sun In" uniqKey="Hong S" first="Sun In" last="Hong">Sun In Hong</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Ryu, Byung Han" sort="Ryu, Byung Han" uniqKey="Ryu B" first="Byung-Han" last="Ryu">Byung-Han Ryu</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Chong, Yong Pil" sort="Chong, Yong Pil" uniqKey="Chong Y" first="Yong Pil" last="Chong">Yong Pil Chong</name><affiliation><nlm:affiliation>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Seungjun" sort="Lee, Seungjun" uniqKey="Lee S" first="Seungjun" last="Lee">Seungjun Lee</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Sunjoo" sort="Kim, Sunjoo" uniqKey="Kim S" first="Sunjoo" last="Kim">Sunjoo Kim</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Ho Cheol" sort="Kim, Ho Cheol" uniqKey="Kim H" first="Ho Cheol" last="Kim">Ho Cheol Kim</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Hong, Kyung Wook" sort="Hong, Kyung Wook" uniqKey="Hong K" first="Kyung-Wook" last="Hong">Kyung-Wook Hong</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Bae, In Gyu" sort="Bae, In Gyu" uniqKey="Bae I" first="In-Gyu" last="Bae">In-Gyu Bae</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Cho, Oh Hyun" sort="Cho, Oh Hyun" uniqKey="Cho O" first="Oh-Hyun" last="Cho">Oh-Hyun Cho</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: zenmd@naver.com.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32544570</idno><idno type="pmid">32544570</idno><idno type="doi">10.1016/j.ijantimicag.2020.106052</idno><idno type="pmc">PMC7293467</idno><idno type="wicri:Area/Main/Corpus">001396</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001396</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.</title><author><name sortKey="Hong, Sun In" sort="Hong, Sun In" uniqKey="Hong S" first="Sun In" last="Hong">Sun In Hong</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Ryu, Byung Han" sort="Ryu, Byung Han" uniqKey="Ryu B" first="Byung-Han" last="Ryu">Byung-Han Ryu</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Chong, Yong Pil" sort="Chong, Yong Pil" uniqKey="Chong Y" first="Yong Pil" last="Chong">Yong Pil Chong</name><affiliation><nlm:affiliation>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Seungjun" sort="Lee, Seungjun" uniqKey="Lee S" first="Seungjun" last="Lee">Seungjun Lee</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Sunjoo" sort="Kim, Sunjoo" uniqKey="Kim S" first="Sunjoo" last="Kim">Sunjoo Kim</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Ho Cheol" sort="Kim, Ho Cheol" uniqKey="Kim H" first="Ho Cheol" last="Kim">Ho Cheol Kim</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Hong, Kyung Wook" sort="Hong, Kyung Wook" uniqKey="Hong K" first="Kyung-Wook" last="Hong">Kyung-Wook Hong</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Bae, In Gyu" sort="Bae, In Gyu" uniqKey="Bae I" first="In-Gyu" last="Bae">In-Gyu Bae</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Cho, Oh Hyun" sort="Cho, Oh Hyun" uniqKey="Cho O" first="Oh-Hyun" last="Cho">Oh-Hyun Cho</name><affiliation><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: zenmd@naver.com.</nlm:affiliation></affiliation></author></analytic><series><title level="j">International journal of antimicrobial agents</title><idno type="eISSN">1872-7913</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (administration & dosage)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Antimalarials (administration & dosage)</term><term>Antiviral Agents (administration & dosage)</term><term>Betacoronavirus (growth & development)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (pathology)</term><term>Drug Therapy, Combination (methods)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (administration & dosage)</term><term>Interferon beta-1b (administration & dosage)</term><term>Lopinavir (administration & dosage)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia (drug therapy)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (pathology)</term><term>Ritonavir (administration & dosage)</term><term>SARS-CoV-2 (MeSH)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adjuvants, Immunologic</term><term>Antimalarials</term><term>Antiviral Agents</term><term>Hydroxychloroquine</term><term>Interferon beta-1b</term><term>Lopinavir</term><term>Ritonavir</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy, Combination</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>COVID-19</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>SARS-CoV-2</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32544570</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7913</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of antimicrobial agents</Title><ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation></Journal><ArticleTitle>Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.</ArticleTitle><Pagination><MedlinePgn>106052</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0924-8579(20)30222-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2020.106052</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Sun In</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Byung-Han</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Yong Pil</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seungjun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sunjoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ho Cheol</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Kyung-Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>In-Gyu</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Oh-Hyun</ForeName><Initials>OH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: zenmd@naver.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Antimicrob Agents</MedlineTA><NlmUniqueID>9111860</NlmUniqueID><ISSNLinking>0924-8579</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>145155-23-3</RegistryNumber><NameOfSubstance UI="D000068576">Interferon beta-1b</NameOfSubstance></Chemical><Chemical><RegistryNumber>2494G1JF75</RegistryNumber><NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>O3J8G9O825</RegistryNumber><NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068576" MajorTopicYN="N">Interferon beta-1b</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Hydroxychloroquine</Keyword><Keyword MajorTopicYN="N">Interferon</Keyword><Keyword MajorTopicYN="N">Lopinavir/ritonavir</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32544570</ArticleId><ArticleId IdType="pii">S0924-8579(20)30222-3</ArticleId><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106052</ArticleId><ArticleId IdType="pmc">PMC7293467</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2020 Apr;20(4):400-402</Citation><ArticleIdList><ArticleId IdType="pubmed">32113509</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2020 Jun;26(6):1345-1348</Citation><ArticleIdList><ArticleId IdType="pubmed">32118533</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2020 Jul 1;180(7):934-943</Citation><ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Nov 19;71(16):2114-2120</Citation><ArticleIdList><ArticleId IdType="pubmed">32427279</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001396 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001396 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32544570
|texte= Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32544570" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |